Relation between Plasma PAI Activity and Adipsin Levels

M C Alessi; G Parrot; E Guenoun; V Seelles; P Vague; I Juhan-Vague

doi:10.1055/s-0038-1649906

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1995; 74(04): 1200-1202
DOI: 10.1055/s-0038-1649906

Letter To The Editor

Schattauer GmbH Stuttgart

Relation between Plasma PAI Activity and Adipsin Levels

M C Alessi

Laboratoire d’ hématologic, Marseille, France

,

G Parrot

Laboratoire d’ hématologic, Marseille, France

,

E Guenoun

Laboratoire d’ hématologic, Marseille, France

,

V Seelles

¹Service de diabétologic, CHU Timone, Marseille, France

,

P Vague

¹Service de diabétologic, CHU Timone, Marseille, France

,

I Juhan-Vague

Laboratoire d’ hématologic, Marseille, France

› Institutsangaben

Abstract

als PDF herunterladen

PDF (192 kb)

Referenzen

References
1 Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Cullen D. Correlation between blood fibrinolytic aetivity, plasminogen activator inhibitor level and relative body weight in normal and obese subjects. Metabolism 1986; 2: 250-253
2 Vague P, Juhan-Vague I, Chabcrt V, Alessi MC, Allan C. Fat distribution and plasminogen activator inhibitor aetivity in non diabetic obese women. Metabolism 1989; 38: 913-915
3 Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tcngborn L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor I. Metabolism 1990; 39: 1044-1048
4 Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen inhibitor 1 levels. A possible link between insulin resistance and athcrothrombosis Diabetologia 1991; 34: 457-462
5 Sylvan A, Rutergard JN, Janunger KG, Sjölund B, Nilsson TK. Normal plasminogen activator inhibitor levels at long-term follow-up after jejunoileal bypass in morbidly obese individuals. Metabolism 1992; 41: 1370-1372
6 Folsom AR, Qamhieh HT, Wing RR, Jeffery RW, Stinson VL, Kuller LH, Wu KK. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 1993; 13: 162-169
7 Sawdey S, Loskutoff DJ. Regulation of murine type 1 plasminogen activity inhibitor (PAI-1) gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor a and transforming growth factorβ J Clin Invest 1991; 88: 1346-1353
8 White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 1992; 267: 9210-9213
9 Flier JS, Cook KS, Usher P, Spiegelman BM. Severely impaired adipsin in genetic and acquired obesity. Science 1987; 237: 405-408
10 Napolitano A, Lowell BB, Damm D, Leibel RL, Ravussin E, Jimerson DC, Lesem MD, Van Dyke DC, Daly PA, Chatis P. Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Metab Disord 1994; 18: 213-218
11 National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes 1979; 28: 1039-1057
12 Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, DeClerck PJ, Serradimigni A, Collen D. Plasma plasminogen activator 1 in angina pectoris. Arteriosclerosis 1989; 9: 362-367
13 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-a: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91
14 Rosen BS, Cook KS, Yaglom J, Groves DL, Volakanis JE, Damm D, White T, Spiegelman BM. Adipsin and complement factor D activity an immune related defect in obesity. Science 1989; 244: 1483-1487
15 Loskutoff DJ. Regulation of PAI-1 gene expression. Fibrinolysis 1991; 5: 197-201